Those are legitimate reasons to offer them
Activin receptor-like kinase 7 suppresses lipolysis to accumulate fat in obesity through downregulation of peroxisome proliferator-activated receptor and C/EBP
This happens because when you stop the treatment, the effects of medication, such as reduced appetite and slower digestion, gradually fade and lead to an increase in hunger cravings and higher calorie intake
If this occurs, slight dose adjustment (increasing by 50mcg if not already at 500mcg) may help
Those with significant fat loss goals Individuals with 50+ pounds to lose may benefit from extended protocols with strategic breaks rather than aggressive dosing
It is recommended to check Hematocrit, reticulocyte count, vitamin B12, folate, and iron levels before treatment begins